Anti-human FceR2 / CD23 (Lumiliximab Biosimilar) Beta chemokine receptor-like 1 Mutations in this gene cause

Mutations in this gene cause Alexander disease

These modifications include the covalent attachment of methyl or acetyl groups to lysine and arginine amino acids and the phosphorylation of serine or threonine

: IHC0181R

Number Component 50T Concentration Storage 1 PBS Buffer (powder) 2L x 2 20x RT 2 Antigen Retrieval Buffer 20ml 100x 2-8°C 3 Endogenous Peroxidase Blocking Buffer 3ml RTU 2-8°C 4 Blocking Buffer 3ml RTU 2-8°C 5 Primary Antibody (Human Integrin alpha 2 Recombinant Rabbit mAb) 6ml RTU 2-8°C 6 Secondary Antibody (Goat Anti-Rabbit IgG H&L / HRP) 6ml RTU 2-8°C 7 Chromogen Component A 0

Anti-human FceR2 / CD23 (Lumiliximab Biosimilar) Beta chemokine receptor-like 1 Mutations in this gene causeApplication ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human Target Target Name FceR2 CD23 Target Uniprot P06734 Overview Catalog# BIO0588SM Product Name Anti human FceR2 CD23 (Lumiliximab Biosimilar) Specifications Conjugation None Clone# Lumiliximab Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower. Reconstitution Dissolve with sterile ddH2O